Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRecruitment status is updated to not recruiting, reflecting that participants are no longer being sought. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a header formatting change for Intervention/Treatment were added, along with a version update to v3.6.0.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a new release of the page content for the LIBRETTO-001 study listing.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe website revision tag was updated from v3.5.3 to v3.5.4, indicating a small deployment update to the page’s framework. It does not imply changes to the study information shown on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedA new publication citation was added to the Publications section, detailing a 2024 Oncologist article on selpercatinib's long-term safety and related RET-activated tumors.SummaryDifference0.0%

- Check57 days agoChange DetectedClinicalTrials.gov’s study details page now reflects a newer software/content release revision (v3.5.3 instead of v3.5.2), without changing any study-specific information.SummaryDifference0.0%

- Check64 days agoChange DetectedResults status changed from 'Results Submitted' (2025-10-20) to 'Results Posted' (2026-04-16), with added text describing the LIBRETTO-001 trial results and phase 2 cohorts. The update indicates public availability of the study results and related documentation.SummaryDifference6%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.